Hans Flaatten1,2, Dylan W De Lange3, Alessandro Morandi4,5, Finn H Andersen6,7, Antonio Artigas8, Guido Bertolini9, Ariane Boumendil10, Maurizio Cecconi11, Steffen Christensen12, Loredana Faraldi13, Jesper Fjølner12, Christian Jung14, Brian Marsh15, Rui Moreno16, Sandra Oeyen17, Christina Agwald Öhman18, Bernardo Bollen Pinto19, Ivo W Soliman20, Wojciech Szczeklik21, Andreas Valentin22, Ximena Watson11, Tilemachos Zaferidis23, Bertrand Guidet24,25,26. 1. Department of Clinical Medicine, University of Bergen, Bergen, Norway. hans.flaatten@uib.no. 2. Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway. hans.flaatten@uib.no. 3. Department of Intensive Care Medicine, University Medical Center, University Utrecht, Utrecht, The Netherlands. 4. Department of Rehabilitation Hospital Ancelle di Cremona, Cremona, Italy. 5. Geriatric Research Group, Brescia, Italy. 6. Department of Anaesthesia and Intensive Care, Ålesund Hospital, Ålesund, Norway. 7. Department of Circulation and Medical Imaging, NTNU, Trondheim, Norway. 8. Department of Intensive Care Medecine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain. 9. Laboratorio di Epidemiologia Clinica, Centro di Coordinamento GiViTI Dipar timento di Salute Pubblica, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Villa Camozzi, 24020, Ranica (Bergamo), Italy. 10. Unite de Recherche en Epidemiologie Systemes d'Information et Mode lisation U707, Institut national de la sante et de la recherche medicale, Paris, France. 11. St George's University Hospital, London, UK. 12. Department of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark. 13. Grande Ospedale Metropolitano Niguarda, Milan, Italy. 14. Department of Cardiology, Pulmonology and Angiology, University Hospital, Düsseldorf, Germany. 15. Mater Misericordiae University Hospital, Dublin, Ireland. 16. Unidade de Cuidados Intensivos Neurocríticos, Hospital de São José, Centro Hospitalar de Lisboa Central, Faculdade de Ciência Médicas de Lisboa, Nova Médical School, Lisbon, Portugal. 17. Department of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium. 18. Karolinska University Hospital, Solna, Sweden. 19. Geneva University Hospitals, Geneva, Switzerland. 20. Department of Intensive Care, University Medical Center, University Utrecht, Utrecht, The Netherlands. 21. Intensive Care and Perioperative Medicine Division, Jagiellonian University Medical College, Kraków, Poland. 22. Kardinal Schwarzenberg Hospital, Schwarzach, Austria. 23. Intensive Care Unit General Hospital of Larissa Tsakalof, Larissa, Greece. 24. Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale, Paris, France. 25. Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. 26. INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
Abstract
PURPOSE: Very old critical ill patients are a rapid expanding group in the ICU. Indications for admission, triage criteria and level of care are frequently discussed for such patients. However, most relevant outcome studies in this group frequently find an increased mortality and a reduced quality of life in survivors. The main objective was to study the impact of frailty compared with other variables with regards to short-term outcome in the very old ICU population. METHODS: A transnational prospective cohort study from October 2016 to May 2017 with 30 days follow-up was set up by the European Society of Intensive Care Medicine. In total 311 ICUs from 21 European countries participated. The ICUs included the first consecutive 20 very old (≥ 80 years) patients admitted to the ICU within a 3-month inclusion period. Frailty, SOFA score and therapeutic procedures were registered, in addition to limitations of care. For measurement of frailty the Clinical Frailty Scale was used at ICU admission. The main outcomes were ICU and 30-day mortality and survival at 30 days. RESULTS: A total of 5021 patients with a median age of 84 years (IQR 81-86 years) were included in the final analysis, 2404 (47.9%) were women. Admission was classified as acute in 4215 (83.9%) of the patients. Overall ICU and 30-day mortality rates were 22.1% and 32.6%. During ICU stay 23.8% of the patients did not receive specific ICU procedures: ventilation, vasoactive drugs or renal replacement therapy. Frailty (values ≥ 5) was found in 43.1% and was independently related to 30-day survival (HR 1.54; 95% CI 1.38-1.73) for frail versus non-frail. CONCLUSIONS: Among very old patients (≥ 80 years) admitted to the ICU, the consecutive classes in Clinical Frailty Scale were inversely associated with short-term survival. The scale had a very low number of missing data. These findings provide support to add frailty to the clinical assessment in this patient group. TRIAL REGISTRATION: ClinicalTrials.gov (ID: NCT03134807).
PURPOSE: Very old critical ill patients are a rapid expanding group in the ICU. Indications for admission, triage criteria and level of care are frequently discussed for such patients. However, most relevant outcome studies in this group frequently find an increased mortality and a reduced quality of life in survivors. The main objective was to study the impact of frailty compared with other variables with regards to short-term outcome in the very old ICU population. METHODS: A transnational prospective cohort study from October 2016 to May 2017 with 30 days follow-up was set up by the European Society of Intensive Care Medicine. In total 311 ICUs from 21 European countries participated. The ICUs included the first consecutive 20 very old (≥ 80 years) patients admitted to the ICU within a 3-month inclusion period. Frailty, SOFA score and therapeutic procedures were registered, in addition to limitations of care. For measurement of frailty the Clinical Frailty Scale was used at ICU admission. The main outcomes were ICU and 30-day mortality and survival at 30 days. RESULTS: A total of 5021 patients with a median age of 84 years (IQR 81-86 years) were included in the final analysis, 2404 (47.9%) were women. Admission was classified as acute in 4215 (83.9%) of the patients. Overall ICU and 30-day mortality rates were 22.1% and 32.6%. During ICU stay 23.8% of the patients did not receive specific ICU procedures: ventilation, vasoactive drugs or renal replacement therapy. Frailty (values ≥ 5) was found in 43.1% and was independently related to 30-day survival (HR 1.54; 95% CI 1.38-1.73) for frail versus non-frail. CONCLUSIONS: Among very old patients (≥ 80 years) admitted to the ICU, the consecutive classes in Clinical Frailty Scale were inversely associated with short-term survival. The scale had a very low number of missing data. These findings provide support to add frailty to the clinical assessment in this patient group. TRIAL REGISTRATION: ClinicalTrials.gov (ID: NCT03134807).
Entities:
Keywords:
Elderly; Frailty; ICU; Mortality; Octogenarians; Severity of illness
Authors: Daren Heyland; Deborah Cook; Sean M Bagshaw; Allan Garland; Henry T Stelfox; Sangeeta Mehta; Peter Dodek; Jim Kutsogiannis; Karen Burns; John Muscedere; Alexis F Turgeon; Rob Fowler; Xuran Jiang; Andrew G Day Journal: Crit Care Med Date: 2015-07 Impact factor: 7.598
Authors: M S Nielsson; C F Christiansen; M B Johansen; B S Rasmussen; E Tønnesen; M Nørgaard Journal: Acta Anaesthesiol Scand Date: 2013-10-13 Impact factor: 2.105
Authors: John Muscedere; Braden Waters; Aditya Varambally; Sean M Bagshaw; J Gordon Boyd; David Maslove; Stephanie Sibley; Kenneth Rockwood Journal: Intensive Care Med Date: 2017-07-04 Impact factor: 17.440
Authors: Hans Flaatten; Dylan deLange; Christian Jung; Michael Beil; Bertrand Guidet Journal: Intensive Care Med Date: 2021-02-19 Impact factor: 17.440
Authors: L E M Haas; Ilse van Beusekom; Diederik van Dijk; Marije E Hamaker; Ferishta Bakhshi-Raiez; Dylan W de Lange; Nicolette F de Keizer Journal: Intensive Care Med Date: 2018-09-25 Impact factor: 17.440
Authors: Christian Jung; Raphael Romano Bruno; Bernhard Wernly; Georg Wolff; Michael Beil; Malte Kelm Journal: Dtsch Arztebl Int Date: 2020-10-02 Impact factor: 5.594
Authors: Tamas Szakmany; Angharad M Walters; Richard Pugh; Ceri Battle; Damon M Berridge; Ronan A Lyons Journal: Crit Care Med Date: 2019-01 Impact factor: 7.598